2,038
Views
2
CrossRef citations to date
0
Altmetric
Editorial

In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers

, , &
Pages 735-738 | Received 20 Sep 2021, Accepted 31 Mar 2022, Published online: 15 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Cody Palmer, Keisuke Tobe, Yusuke Negishi, Xuedan You, Ya-Ting Chen & Machiko Abe. (2023) Health impact and cost effectiveness of implementing gender-neutral HPV vaccination in Japan. Journal of Medical Economics 26:1, pages 1546-1554.
Read now

Articles from other publishers (1)

Matti Lehtinen, Ville N. Pimenoff, Belinda Nedjai, Karolina Louvanto, Lisanne Verhoef, Daniëlle A. M. Heideman, Mariam El‐Zein, Martin Widschwendter & Joakim Dillner. (2022) Assessing the risk of cervical neoplasia in the post‐HPV vaccination era . International Journal of Cancer 152:6, pages 1060-1068.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.